ÂÜÀòÂÒÂ×

David Marsico is an accomplished medical professional with extensive experience in medical science liaison roles and oncology operations. Currently serving as a Medical Science Liaison at Secura Bio, Inc. since February 2022, Marsico previously held the position of Director of Oncology Trials Operations at TG Therapeutics, overseeing investigator-sponsored trial programs and supporting key company-sponsored trials from 2018 to January 2022. With a background as a Clinical Science Liaison and Medical Science Liaison at prominent companies, including TG Therapeutics, Spectrum Pharmaceuticals, and Celgene, Marsico has a proven track record in building relationships with hematologists and oncologists, supporting investigational agents, and enhancing clinical awareness across various oncologic and hematologic malignancies. Marsico's education includes a Bachelor of Science in Pharmacy and an MBA in Marketing and Finance from The Ohio State University.